INVO BIOSCIENCE

INVO Bioscience is a medical device company founded by Claude Ranoux, MD, MS, a noted expert in the field of reproductive health, infertility and embryology. Dr. Ranoux developed the INVO Procedure, the process of using intra-vaginal culture (IVC) and the INVOcellโข, a novel biological capsule, for oocyte (egg) fertilization and early-stage embryo development in the womanโs vaginal cavity.
INVO BIOSCIENCE
Industry:
Biotechnology Health Care Medical Device
Founded:
2008-01-01
Address:
Medford, Massachusetts, United States
Country:
United States
Website Url:
http://www.invobioscience.com
Total Employee:
1+
Status:
Active
Contact:
978-878-9505
Email Addresses:
[email protected]
Total Funding:
4.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Impel NeuroPharma
Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
The Cooper Companies
The Cooper Companies, Inc. (Cooper) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO).
Current Employees Featured
Founder
Stock Details
Investors List
Daniel Schryer
Daniel Schryer investment in Convertible Note - Invo Bioscience
Daniel Schryer
Daniel Schryer investment in Post-IPO Debt - Invo Bioscience
Key Employee Changes
Date | New article |
---|---|
2021-07-14 | INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration |
2021-06-15 | Invo Bioscience names chief financial officer |
Official Site Inspections
http://www.invobioscience.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K
- Host name: 104.21.47.47
- IP address: 104.21.47.47
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Invo Bioscience"
Invo Bioscience - Crunchbase Company Profile & Funding
Organization. Invo Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; โฆSee details»
INVOBioscience - Org Chart, Teams, Culture & Jobs | The Org
View INVOBioscience's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
INVO Bioscience - LinkedIn
INVO Bioscience | 1,263 followers on LinkedIn. Life Begins Within | At INVO bioscience, we are democratizing fertility. Our mission is to help people realize the dream of parenthood by increasing ...See details»
ABOUT US - INVO Bioscience
The INVOcell story . INVO Bioscience is dedicated to making fertility care accessible and inclusive to people around the world. Our flagship product is INVOcell, a revolutionary reproductive โฆSee details»
THE TEAM - INVO Bioscience
April McGhee VP of Clinical Operations. April joined INVO Bioscience in September of 2022. April has over 20 year of experience in the medical...See details»
INVO Bioscience - Craft
Oct 29, 2024 INVO Bioscience $3.02 m in annual revenue in FY 2023. See insights on INVO Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Invo Bioscience - businessabc.net
Feb 25, 2025 Invo Bioscience was founded in 2012 to address the unmet need of making in-vivo Intra-Cytoplasmic Sperm Injection (ICSI) more accessible and affordable, while preserving the โฆSee details»
INVO Bioscience - Company Profile - Tracxn
Jan 11, 2025 INVO Bioscience - Biological device for intravaginal culture and fertilization. Public Company. Raised funding over 6 rounds from 1 investor. Founded by Claude Ranoux in the โฆSee details»
Invo Bioscience - PitchBook
Invo Bioscience General Information Description. NAYA Biosciences operates a healthcare services fertility business as well as expand its focus to the development of first-in-class โฆSee details»
INVO Bioscience Launches New Corporate Website - PR Newswire
Oct 4, 2016 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcellโข,...See details»
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy ...
Jan 17, 2024 INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced, entrepreneurial leadership team to โฆSee details»
Invo Bioscience - Overview, News & Similar companies - ZoomInfo
Popular Searches INVO Bioscience INVO BioScience Inc Bioscience Inc INVOBioscience Biosciences SIC Code 87,873 NAICS Code 54,541 Ticker OTC: INVO Show more. Similar โฆSee details»
Francisco Arredondo MD, MPH, FACOG โ INVO Bioscience®
His determination to become a fertility specialist led him to do: research at the World Health Organizationโs Reproductive Biology Center in Mexico City; an internship in Kahn Mount Sinai โฆSee details»
INVOBioscience - Facebook
INVOBioscience, South Sarasota, Florida. 374 likes. Life Begins Within. We are a commercial-stage fertility company expanding access to advanced treatment worldwide.See details»
Matthew Szot - Chief Financial Officer - Cadrenal ... - LinkedIn
Chief Financial Officer at Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) - advancing its late-stage drug candidate tecarfarin, a new blood thinner for patients with implanted cardiac devices and โฆSee details»
INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA
BEVERLY, Mass., Jan. 20, 2012 /PRNewswire/ -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, โฆSee details»
INVO Bioscience Investors - Facebook
INVO Bioscience Investors. 154 likes. This is a community page for INVO Bioscience current and future investors. Here we can share informaSee details»
Michael J. Campbell โ INVO Bioscience®
Michael J. Campbell COO and VP, Business Development. Mike joined INVO Bioscience as COO and VP of Business Development in 2019. He was most recently the Vice President of IVF โฆSee details»
Establishing Canadaโs first large-scale bioinnovation centre
3 days ago Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth โ Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to โฆSee details»
J. Chris Jensen โ INVO Bioscience®
J. Chris Jensen VP of Engineering, Quality and Regulatory Affairs. Chris joined INVO Bioscience in 2020 as the Vice President of Quality and Regulatory Affairs.See details»